Hematopoietic chimerism, tolerance induction and graft-versus-host disease: considerations for composite tissue transfer. - Suppr | 超能文献

Hematopoietic chimerism, tolerance induction and graft-versus-host disease: considerations for composite tissue transfer.

作者信息

Exner B G, Acholonu I, Ildstad S T

机构信息

Institute for Cellular Therapeutics, Allegheny University of the Health Sciences, Philadelphia, PA 19102, USA.

出版信息

Transplant Proc. 1998 Sep;30(6):2718-20. doi: 10.1016/s0041-1345(98)00795-7.

DOI:10.1016/s0041-1345(98)00795-7

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Hematopoietic chimerism, tolerance induction and graft-versus-host disease: considerations for composite tissue transfer.

Transplant Proc. 1998 Sep;30(6):2718-20. doi: 10.1016/s0041-1345(98)00795-7.

2

Mixed chimerism for the induction of tolerance: potential applicability in clinical composite tissue grafting.混合嵌合体诱导免疫耐受：在临床复合组织移植中的潜在应用。

Transplant Proc. 1998 Sep;30(6):2708-10. doi: 10.1016/s0041-1345(98)00793-3.

3

Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.间充质干细胞增强骨髓移植后大鼠后肢同种异体移植物混合嵌合体的诱导和耐受。

J Surg Res. 2010 May 15;160(2):315-24. doi: 10.1016/j.jss.2008.09.027. Epub 2008 Nov 4.

4

Mixed allogeneic chimerism and tolerance to composite tissue allografts.

Microsurgery. 2000;20(8):441-7. doi: 10.1002/1098-2752(2000)20:8<441::aid-micr16>3.0.co;2-a.

5

Basic science foundation for clinical composite tissue transplantation.临床复合组织移植的基础科学依据

Transplant Proc. 2001 Feb-Mar;33(1-2):1717-9. doi: 10.1016/s0041-1345(00)02655-5.

6

Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.使用去除T细胞的抗体、环磷酰胺和胸腺照射进行非清髓性预处理后诱导稳定的长期混合造血嵌合状态，可导致供体特异性的体外和体内耐受。

Biol Blood Marrow Transplant. 2001;7(12):646-55. doi: 10.1053/bbmt.2001.v7.pm11787527.

7

Donor chimera model for tolerance induction in transplantation.供者嵌合体模型诱导移植中的免疫耐受。

Hum Immunol. 2013 May;74(5):550-6. doi: 10.1016/j.humimm.2013.01.003. Epub 2013 Jan 24.

8

Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation.通过骨髓移植和照射来优化嵌合体水平，以诱导对复合组织同种异体移植的长期耐受。

J Surg Res. 2012 Nov;178(1):487-93. doi: 10.1016/j.jss.2012.02.064. Epub 2012 Mar 17.

9

Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.对晚期血液系统恶性肿瘤患者进行非清髓性预处理的异基因造血细胞移植。

Cytotherapy. 2001;3(4):253-60. doi: 10.1080/146532401317070880.

10

Commentary on "Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation".关于“通过骨髓移植和照射优化嵌合水平以诱导对复合组织同种异体移植的长期耐受”的评论

J Surg Res. 2013 Nov;185(1):e59-60. doi: 10.1016/j.jss.2012.05.021. Epub 2012 May 23.

引用本文的文献

1

Hematologic aspects of myeloablative therapy and bone marrow transplantation.清髓性疗法及骨髓移植的血液学方面

J Clin Lab Anal. 2005;19(2):47-79. doi: 10.1002/jcla.20055.